Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 21;6(7):e1000106.
doi: 10.1371/journal.pmed.1000106. Epub 2009 Jul 21.

Focusing on quality patient care in the new global subsidy for malaria medicines

Suerie Moon  1 , Carmen Pérez Casas, Jean-Marie Kindermans, Martin de Smet, Tido von Schoen-Angerer
Affiliations

Focusing on quality patient care in the new global subsidy for malaria medicines

Suerie Moon et al. PLoS Med. .

Abstract

Tido von Schoen-Angerer and colleagues discuss the new Affordable Medicines Facility for malaria (AMFm), which subsidizes and facilitates access to artemisinin-based combination therapy, and what mechanisms are needed to ensure it stays focused on quality patient care.

PubMed Disclaimer

Conflict of interest statement

JMK was an unpaid member of the Committee on the Economics of Antimalarial Drugs for the Institute of Medicine 2004 report “Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance,” which first proposed a subsidy. JMK and TvSA have been consulted as stakeholders during the preparation of the technical proposal of the AMFm, but none of the authors had any role in the design nor any other official role.

Figures

Figure 1
Figure 1. Evolution of prices for ACT adult treatment.
Sources of prices are as follows: Artemether/lumefantrine (Novartis): Publicly announced prices by Novartis September 29, 2006 ; Novartis April 23, 2008 , and WHO May 16, 2007 . Artemether/lumefantrine (generic): Prices quoted to MSF (manufacturer: Ajanta) followed by prices announced by Clinton HIV/AIDS Initiative (manufacturers: Cipla, IPCA) July17, 2008 . Artesunate/amodiaquine FDC (DNDi/sanofi-aventis): Prices paid by MSF Logistique to manufacturer (MSF internal data). See also sanofi-aventis/DNDi announcement . Artesunate/amodiaquine co-blister average WHO/UNICEF co-tenders: average price from five tenders . Artemisinin (raw material): . The artemisinin raw material considered here as the quantity needed for production of one adult treatment course with artesunate/amodiaquine is 613 mg and 839 mg with artemether/lumefantrine (in both cases with 5% lost during manufacturing).
See this image and copyright information in PMC

References

    1. World Health Organization. The use of antimalarial drugs: Report of an informal consultation, 13–17 Nov 2000. WHO/CDS/RBM/2001.33. 2001. Available: http://www.who.int/malaria/cmc_upload/0/000/014/923/use_of_antimalarials.... Accessed 29 April 2009.
    1. World Health Organization. World malaria report 2008. WHO/HTM/GMP/2008.1. 2008. Available: http://www.who.int/malaria/wmr2008/. Accessed 29 April 2009.
    1. Yeung S, Van Damme W, Socheat D, White N, Mills A. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J. 2008;7:96. - PMC - PubMed
    1. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, et al. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359:2619–2620. - PubMed
    1. World Health Organization. Global malaria control and elimination: Report of a meeting on containment of artemisinin tolerance, 19 January 2008. 2008. Available: http://www.who.int/malaria/docs/drugresistance/Malaria_Artemisinin.pdf. Accessed 29 April 2009.

MeSH terms